Faeth Therapeutics Inc (FTH) 13F Positioning & Ownership Changes (Q2 2026)

FTH ranks #6453 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

FTH is a top-conviction position for B Group, Inc. — at 7.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in FTH belongs to Montanova Capital, LLC, but the position matters far more to B Group, Inc., who has 7.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

FTH is down 8.7% today, but institutions show net buying of $293.8M this quarter — a divergence between today's price move and the underlying institutional flow.

FTH reported a net loss of $21.1M in its latest fiscal year.

• Not yet profitable — net loss of $21.1M in the latest fiscal year
• Net income improved year over year, from -$30.2M to -$21.1M
• Operating cash flow was negative, using $20.5M in cash
• Current ratio of 5.06x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.23x equity — within a conventional range